Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I like the diversity of topics that MedCity News covers – ranging from devices to policy to start-up companies. Always something interesting to find.”

Robert J. Szczerba, Ph.D., CEO, X Tech Ventures


Sign up for our daily newsletter


SPR Therapeutics implants shoulder-pain device in first stroke patient

2:19 pm by | 0 Comments

SPR Therapeutics' Smart patch

Neurostimulation startup SPR Therapeutics has reached an important milestone, implanting its post-stroke shoulder-pain device in a patient for the first time.

A 76-year-old man suffering from shoulder pain is now pain-free after being implanted with the device at Carolinas Medical Center in Charlotte, North Carolina. The patient also reported a better quality of life, with improvements in sleep, mood and relationships with other, according to a statement from Cleveland-area SPR.

SPR’s pain-relief system is aimed at reducing shoulder pain in patients who’ve suffered strokes. The technology works via an external generator that electrically stimulates a peripheral nerve to exercise a muscle and treat a patient’s pain.

Advertisement

SPR has developed a two-stage process for pain relief: First, a patient is treated with the company’s short-term device, the Smartpatch. Next, the patient is implanted with the company’s MicroPulse long-term MicroPulse device.

SPR is also studying its system in patients suffering shoulder pain not related to stroke.

The company recently filed a regulatory document indicating it had raised $1 million of an anticipated $2 million series A round of investment.

CEO Maria Bennett wasn’t available for comment.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Brandon Glenn

By Brandon Glenn MedCity News

Brandon Glenn is the Ohio bureau chief for MedCity News.
More posts by Author

0 comments

Hear the latest news first

Get our daily newsletter or follow us.

 

Advertisement